Some patients and families with JPS and SMAD4 mutation exhibit a phenotype of HHT with epistaxis, telangiectasia and visceral AVM, particularly hepatic and pulmonary, without a genetic HHT mutation. This evidence concerns the gene SMAD4 and hereditary hemorrhagic telangiectasia.